Detection of colorectal cancer (CRC) by urinary volatile organic compound analysis

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Arasaradnam, Ramesh P ^a,b   Mcfarlane, Michael J ^b   Ryan Fisher, Courtenay ^b   Westenbrink, Erik ^a   Hodges, Paula ^b   Thomas, Matthew G ^a   Chambers, Samantha ^a   O'Connell, Nicola ^b   Bailey, Catherine ^b   Harmston, Christopher ^b   Nwokolo, Chuka U ^b   Bardhan, Karna D ^a,c   Covington, James A ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

^b UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

^c ROTHERHAM GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VOLATILE ORGANIC COMPOUND; TUMOR MARKER;

ARTICLE; CANCER CLASSIFICATION; CANCER STAGING; CHEMICAL ANALYSIS; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; FIELD ASYMMETRIC ION MOBILITY SPECTROMETER; GAS CHROMATOGRAPH; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS FRAGMENTOGRAPHY; NON INVASIVE PROCEDURE; SENSITIVITY AND SPECIFICITY; SPECTROMETER; URINALYSIS; ADULT; AGED; CLUSTER ANALYSIS; COLORECTAL NEOPLASMS; DISCRIMINANT ANALYSIS; MASS SPECTROMETRY; MIDDLE AGED; URINE;

ADULT; AGED; CLUSTER ANALYSIS; COLORECTAL NEOPLASMS; DISCRIMINANT ANALYSIS; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; VOLATILE ORGANIC COMPOUNDS;

EID: 84907495547     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0108750     Document Type: Article

References (30)

1. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics. CA Cancer J Clin 62(1): 10-29.
2. Ferlay J, Parkin DM, Steliarova-Foucher E (2010) Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 46: 765-81
3. Brenner H, Tao S (2013) Superior diagnostic performance of faecal immunochemical tests for haemoglobin in a head-to-head comparison with guaiac based faecal occult blood test among 2235 participants of screening colonoscopy. Eur J Cancer 49 (14): 3049-54
4. Imperiale TF (2012) Non-invasive screening tests for colorectal cancer. Dig Dis 30 Suppl 2: 16-26.
5. De Meij TG, Ben Larbi I, van der Schee MP, Lentferink YE, Paff T, et al. (2014) Electronic nose can discriminate colorectal carcinoma and advanced adenomas by fecal volatile biomarker analysis: proof of principle study. Int J Cancer 134(5): 1132-1138.
6. Lippi G, Cervellin G (2012) Canine olfactory detection of cancer versus laboratory testing: myth or opportunity? Clin Chem Lab Med 50(3): 435-9
7. Sonoda H, Kohnoe S, Yamazato T, Satoh Y, Morizono G, et al. (2011) Colorectal cancer screening with odour material by canine scent detection. Gut 60(6): 814-9
8. Arasaradnam RP, Nwokolo CU, Bardhan KD, Covington JA (2011) Electronic nose versus canine nose: clash of the titans. Gut 60(12): 1768
9. Westhoff M, Litterst P, Maddula S, Bödeker B, Rahmann S, et al. (2010) Differentiation of chronic obstructive pulmonary disease (COPD) including lung cancer from healthy control group by breath analysis using ion mobility spectrometry. International Journal for Ion Mobility Spectrometry 13(3-4): 131-139.
10. Phillips M, Cataneo RN, Ditkoff BA, Fisher P, Greenberg J, et al. (2003) Volatiles markers of breast cancer in the breath. The Breast J 9: 184-191.
11. Khalid T, White P, De Lacy Costello B, Persad R, Ewen R, et al. (2013) A Pilot Study Combining a GC-Sensor Device with a Statistical Model for the Identification of Bladder Cancer from Urine Headspace. PLoS ONE 8(7): e69602.
12. Bernabei M, Pennazza G, Santonico M, Corsi C, Roscion C, et al. (2008) A preliminary study on the possibility to diagnose urinary tract cancers by an electronic nose. Sens Actuat B Chem 131, 1-4.
13. Arasaradnam RP, Covington JA, Harmston C, Nwokolo CU (2014) Next generation diagnostic modalities in gastroenterology - gas phase volatile compound biomarker detection. Alimentary Pharmacology and Therapeutics 39 (8): 780-789.
14. Peng G, Hakim M, Broza YY, Billan S, Abdah-Bortnyak R, et al. (2010) Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors. Br J Cancer 103(4):542-51
15. Altomare DF, Di Lena M, Porcelli F, Trizio L, Travaglio E, et al. (2013) Exhaled volatile organic compounds identify patients with colorectal cancer. Br J Surg 100(1): 144-50.
16. Silva CL, Passos M, Câmara JS (2011) Investigation of urinary volatile organic metabolites as potential cancer biomarkers by solid-phase microextraction in combination with gas chromatography-mass spectrometry. Br J Cancer 105(12): 1894-904.
17. Probert CS, Ahmed I, Khalid T, Johnson E, Smith S, et al. (2009) Volatile organic compunds as diagnostic biomarkers in gastronintestinal and liver disease. J Gastroninestin Liver Dis 18: 337-4-3
18. Arasaradnam RP, Pharaoh MW, Williams GJ, Nwokolo CU, Bardhan KD, et al. (2009) Colonic fermentation-more than meets the nose. Med Hypotheses 73(5): 753-6
19. Buszewski B, Kesy M, Ligor T, Amann A (2007) Human exhaled air analytics: biomarkers of disease. Biomed Chromatogr 21: 533-66
20. Garner CE, Smith S, de Lacy Costello B, White P, et a.l (2007) Volatile organic compounds from feces and their potential for diagnosis of gastrointestinal disease. FASEBJ 21: 1675-88
21. Arasaradnam RP, Quraishi N, Kyrou I, Nwokolo CU, Joseph M, et al. (2011) Insights into 'Fermente no mies': Evaluation of volatile organic compounds (VOCs) in human disease using an Electronic 'e' Nose. J Med Eng Technol 35(2):87-91.
22. Arasaradnam RP, Ouaret N, Thomas MG, Gold P, Quraishi MN, et al. (2012) Evaluation of gut bacterial populations using an electronic e-nose and field asymmetric ion mobility spectrometry: further insights into 'fermentonomics'. J Med Eng Technol 36(7):333-7.
23. Covington JA, Westenbrink EW, Ouaret N, Harbord R, Bailey C, et al. (2013) Application of a novel tool for diagnosing bile acid diarrhoea. Sensors (Basel) 13(9): 11899-912
24. Arasaradnam RP, Bardhan KD (2010) Bioactive foods and Extracts - Cancer treatment and prevention. Taylor Francis, New York.
25. Covington JA, Wedlake L, Andreyev J, Ouaret N, Thomas MG, et al. (2012) The detection of patients at risk of gastrointestinal toxicity during pelvic radiotherapy by electronic nose and FAIMS: a pilot study. Sensors (Basel) 12(10): 13002-18
26. Arasaradnam RP, Ouaret N, Thomas MG, Quraishi N, Heatherington E, et al. (2013) A novel tool for noninvasive diagnosis and tracking of patients with inflammatory bowel disease. Inflamm Bowel Dis 19(5): 999-1003.
27. Arasaradnam R, Westinbrink E, McFarlane M, Harbord R, Chambers S, et al (2014) Differentiating Coeliac disease from irritable bowel syndrome by urinary volatile organic compound analysis - a pilot study. PLOS One (in press)
28. Lidgard GP, Domanico MJ, Bruinsma JJ, Light J, Gagrat ZD, et al. (2013) Clinical performance of an automated stool DNA assay for detection of colorectal neoplasia. Clin Gastroenterol Hepatol 11(10): 1313-8
29. Pagnini C, Corlete VD, Mangoni ML, Pilozzi E, Torre MS, et al. (2011) Alteration of local microflora and α-defensins hyper-production in colonic adenoma mucosa. J Clin Gastroenterol 45(7): 602-10.
30. Moss SM, Campbell C, Melia J, Coleman D, Smith S, et al. (2012) Performance measures in three rounds of the English bowel cancer screening pilot. Gut 61(1): 101-7.